本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

7.24
-0.3200-4.23%
盘后:7.240.00000.00%16:10 EDT
成交量:321.42万
成交额:2,368.03万
市值:15.85亿
市盈率:-5.12
高:7.61
开:7.55
低:7.20
收:7.56
52周最高:16.44
52周最低:6.23
股本:2.19亿
流通股本:1.85亿
量比:1.01
换手率:1.74%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
净资产收益率:-72.99%
总资产收益率:-34.95%
市净率:3.05
市盈率(LYR):-5.10

数据加载中...

2021/09/22

重要事件披露

8-K - Current report
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/07/22

重要事件披露

8-K - Current report
2021/06/22

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report